Research related to the investigation of metabolic pathways and mechanisms as well as metabolic diseases such as diabetes and osteoporosis fit into this emphasis. The emphasis may also include investigations on the gut-liver axis, liver and pancreas function (including islet cells) as well as on metabolism in fat tissues and other pathologically altered tissues and tumors. Studies on therapeutic interventions (e.g. new drugs or cell transplantations) will also be considered.
Probes & Targets
The design, chemical synthesis and characterization of imaging probes and theranostic agents as well as reporter genes used to study metabolic pathways and diseases will be addressed. All imaging modalities will be covered.
Research on metabolic pathways and diseases that include new imaging tools, probes and therapeutics and its testing on cells or animals belong to this category. It also includes the preclinical testing of image-guided therapies.
In this category, research on metabolism and metabolic diseases will be presented that mainly addresses new biological mechanisms and where imaging is rather used as a tool to gain the mechanistic insights. New approaches in bioengineering and new disease models will also be considered.
Translational and Human Studies
Research on metabolic diseases in humans or (non-human) studies with demonstrated potential for clinical impact or immediate translation should be submitted to this category. It includes prospective and retrospective studies as well as studies on new pharmaceuticals at phase I-IV. Studies on Omics and its combination with imaging are also welcome.